ArticleDiscover mental health2026
Uncovering gaps in HIV care in belgium through patient reported outcome measures and neurocognitive screening.
Article in Discover mental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatient-reported outcome measures (PROMs) are critical for evaluating health-related quality of life (HRQoL) among people living with HIV (PLHIV). This study explores HRQoL using PROMs and assesses the prevalence and implications of HIV-associated neurocognitive disorders (HAND) within the HIV Reference Centre (HRC) of Ghent University Hospital, a tertiary outpatient clinic providing routine multidisciplinary HIV care.
methodsBetween November 2021 and June 2023, 836 of 1,473 PLHIV followed completed a PROMs questionnaire assessing physical and mental health, sleep, social support, sexual health, stigma, and substance use. Screening for HAND was conducted using the European AIDS Clinical Society (EACS) guidelines, Montreal Cognitive Assessment (MoCA), and International HIV Dementia Scale (IHDS).
resultsSeventy-seven percent of the participants were male and mean age was 52 years (SD = 11.68). Satisfaction rates were high for physical (77%) and mental health (71%). Notably, 47% reported significant sleep disturbances, and 18.5% regularly used substances. Forty-four percent reported one or more neurocognitive complaints on the EACS screening questions, of whom 14% had impairment across all three cognitive domains. Of those reporting complaints, 36% underwent formal cognitive screening; within this screened subgroup, impaired scores were identified in 45% on the MoCA and 63% on the IHDS. Regression analyses indicated that negative feelings, sleep difficulties, low social support, and neurocognitive functioning significantly predicted overall HRQoL.
conclusionsSleep, substance use, and neurocognitive functioning emerge as points of interest among Belgian PLHIV. Systematic identification of cognitive difficulties-when integrated with appropriate referral pathways, cardiovascular risk management, and psychosocial support rather than as isolated screening-may contribute to preserving HRQoL. The potential benefits of screening must be weighed against the risk of increasing anxiety among PLHIV.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.